CY2021A - Stabilized solutions of platinum (ii) antitumor agents - Google Patents

Stabilized solutions of platinum (ii) antitumor agents

Info

Publication number
CY2021A
CY2021A CY202198A CY202198A CY2021A CY 2021 A CY2021 A CY 2021A CY 202198 A CY202198 A CY 202198A CY 202198 A CY202198 A CY 202198A CY 2021 A CY2021 A CY 2021A
Authority
CY
Cyprus
Prior art keywords
platinum
antitumor agents
solutions
stabilized solutions
oxygen
Prior art date
Application number
CY202198A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22307943&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY2021(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of CY2021A publication Critical patent/CY2021A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CY202198A 1993-08-11 1998-02-20 Stabilized solutions of platinum (ii) antitumor agents CY2021A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/105,817 US5455270A (en) 1993-08-11 1993-08-11 Stabilized solutions of platinum(II) antitumor agents

Publications (1)

Publication Number Publication Date
CY2021A true CY2021A (en) 1998-02-20

Family

ID=22307943

Family Applications (1)

Application Number Title Priority Date Filing Date
CY202198A CY2021A (en) 1993-08-11 1998-02-20 Stabilized solutions of platinum (ii) antitumor agents

Country Status (24)

Country Link
US (1) US5455270A (ru)
EP (1) EP0642792B1 (ru)
JP (1) JP3629044B2 (ru)
KR (1) KR100351713B1 (ru)
CN (1) CN1082813C (ru)
AT (1) ATE152349T1 (ru)
AU (1) AU685126B2 (ru)
CA (1) CA2128641A1 (ru)
CY (1) CY2021A (ru)
CZ (1) CZ188494A3 (ru)
DE (1) DE69402931T2 (ru)
DK (1) DK0642792T3 (ru)
ES (1) ES2102743T3 (ru)
FI (1) FI113618B (ru)
GR (1) GR3024340T3 (ru)
HK (1) HK115497A (ru)
HU (1) HU220074B (ru)
IL (1) IL110577A (ru)
NO (1) NO308288B1 (ru)
NZ (1) NZ264210A (ru)
PL (1) PL178689B1 (ru)
RU (1) RU2142797C1 (ru)
TW (1) TW383224B (ru)
ZA (1) ZA946007B (ru)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100365171B1 (ko) * 1994-08-08 2003-02-19 드바이오팜 에스.아. 약학적으로안정한옥살리플라티늄제제
US20040072889A1 (en) * 1997-04-21 2004-04-15 Pharmacia Corporation Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia
ES2399480T3 (es) * 1997-11-10 2013-04-01 Memorial Sloan-Kettering Cancer Center Procedimiento de producción de formulaciones de trióxido de arsénico
GB9804013D0 (en) * 1998-02-25 1998-04-22 Sanofi Sa Formulations
CZ292170B6 (cs) * 1998-08-14 2003-08-13 Pliva-Lachema A.S. Farmaceutická kompozice s protinádorovým účinkem na bázi carboplatiny
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
BRPI0013613B8 (pt) * 1999-08-30 2021-05-25 Debiopharm Sa composição farmacêuticamente estável de oxaliplatina para administração parenteral.
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
CN1121380C (zh) * 2000-03-03 2003-09-17 北京兴大豪斯科技有限公司 一种抗肿瘤的双二羧酸二氨络铂衍生物及其药物组合物
AUPQ641100A0 (en) * 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
DE10032256C2 (de) * 2000-07-03 2003-06-05 Infineon Technologies Ag Chip-ID-Register-Anordnung
KR100363394B1 (ko) * 2000-08-21 2002-12-05 한국과학기술연구원 온도감응성을 갖는 포스파젠삼량체-백금착물 복합체, 그의제조방법 및 그를 함유하는 항암제 조성물
WO2003045962A1 (fr) * 2001-11-30 2003-06-05 Jingzun Wang Derives de carboplatine supramoleculaires, leur preparation, compositions pharmaceutiques les contenant comme ingredient actif et utilisations de ces compositions
US6476068B1 (en) * 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
FR2841784B1 (fr) * 2002-07-08 2007-03-02 Composition a base de derives de 1,3-diphenylprop-2en-1-one substitues, preparation et utilisations
AU2005329764B2 (en) * 2005-03-28 2010-08-12 Dabur Pharma Ltd. Stable pharmaceutical compositions of platinum (II) antitumour agents
WO2007074641A1 (ja) * 2005-12-29 2007-07-05 Nipro Corporation 白金錯体を含有する水溶液医薬製剤
CN101723982B (zh) * 2008-10-31 2013-01-02 齐鲁制药有限公司 具有抗癌活性的合铂化合物及其合成方法
ES2765648T3 (es) * 2015-04-10 2020-06-10 Syn Nat Products Entpr Llc Procedimiento para la preparación de dicicloplatino
CA2986136A1 (en) * 2015-05-18 2016-11-24 Syn-Nat Products Enterprise LLC A pharmaceutical co-crystal and use thereof
CN105726475B (zh) * 2016-04-12 2018-05-04 青岛市妇女儿童医院 一种治疗晚期卵巢癌的注射液及其制备方法
CN108143714A (zh) * 2016-04-12 2018-06-12 夏建明 一种用于治疗晚期卵巢癌的注射液及其制备方法
CN106188150A (zh) * 2016-04-13 2016-12-07 范如霖 一类碳铂复合物抗癌药及其制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH605550A5 (ru) * 1972-06-08 1978-09-29 Research Corp
US4657927A (en) * 1978-05-04 1987-04-14 Research Corporation Malonato platinum compounds
CH672109A5 (ru) * 1987-01-30 1989-10-31 Wiedmer Plastikform W
JPH01146826A (ja) * 1987-12-03 1989-06-08 Nippon Kayaku Co Ltd 白金化合物の凍結乾燥製剤
IL85790A0 (en) * 1988-03-20 1988-09-30 Abic Ltd Solution of carboplatin
US5041578A (en) * 1988-11-22 1991-08-20 Board Of Regents, The University Of Texas System Water soluble 1,2-diaminocyclohexane platinum (IV) complexes as antitumor agents
NL8901433A (nl) * 1989-06-06 1991-01-02 Pharmachemie Bv Carboplatinpreparaat.

Also Published As

Publication number Publication date
RU94028650A (ru) 1996-11-10
DE69402931T2 (de) 1997-12-18
ATE152349T1 (de) 1997-05-15
AU6898294A (en) 1995-02-23
NO942944D0 (no) 1994-08-09
NZ264210A (en) 1995-10-26
FI943666A0 (fi) 1994-08-08
FI943666A (fi) 1995-02-12
CN1082813C (zh) 2002-04-17
US5455270A (en) 1995-10-03
TW383224B (en) 2000-03-01
NO942944L (no) 1995-02-13
DK0642792T3 (da) 1997-10-20
PL304601A1 (en) 1995-02-20
HK115497A (en) 1997-08-29
RU2142797C1 (ru) 1999-12-20
CZ188494A3 (en) 1995-02-15
CN1118252A (zh) 1996-03-13
JP3629044B2 (ja) 2005-03-16
CA2128641A1 (en) 1995-02-12
KR100351713B1 (ko) 2002-12-28
KR950005305A (ko) 1995-03-20
IL110577A (en) 2000-06-01
EP0642792A1 (en) 1995-03-15
PL178689B1 (pl) 2000-06-30
HU220074B (hu) 2001-10-28
HU9402307D0 (en) 1994-10-28
AU685126B2 (en) 1998-01-15
HUT75154A (en) 1997-04-28
DE69402931D1 (de) 1997-06-05
GR3024340T3 (en) 1997-10-31
ZA946007B (en) 1995-02-10
ES2102743T3 (es) 1997-08-01
FI113618B (fi) 2004-05-31
EP0642792B1 (en) 1997-05-02
JPH0753368A (ja) 1995-02-28
NO308288B1 (no) 2000-08-28
IL110577A0 (en) 1994-11-11

Similar Documents

Publication Publication Date Title
CY2021A (en) Stabilized solutions of platinum (ii) antitumor agents
EP0098135A3 (en) Solubilized platinum(ii) complexes
EP1069121A4 (en) REAGENT FOR DETECTING SINGULET OXYGEN
PT881226E (pt) Processo de preparacao de compostos de platina
ES2099013A1 (es) Nuevos compuestos de polimetilpiperidina con grupos de silano y su uso como estabilizantes para materiales organicos.
AU551841B2 (en) Diamide pest control agents
EP1431347A4 (en) COMPOSITION CONTAINING FINE PARTICLES FOR CARRIERING BIOLOGICAL ACTIVE SUBSTANCES OR BIOLOGICAL ACTIVITIES BASED ON THEM, AND METHOD OF PRODUCTION THEREOF
SG48485A1 (en) Stabilization of non-halogenated 3-isothiazolones in aggressive systems
TR21241A (tr) 4 - halo - s*bstit*e edilmis sakaroz t*revleri
ATE166205T1 (de) Tb-wirksame carbonsäure
ES2159262A1 (es) Compuestos aminicos estericamente impedidos.
ZA881430B (ru)
AU623986B2 (en) Platinum complexes and antitumor agents containing them as an active ingredient
GB1458063A (en) 4-m,m-di-ti-butyl-p-hydroxyphenyl-butyl-2 compounds
EP0978281A4 (en) EYE DROPS
ES2096838T3 (es) Soluciones estables al almacenamiento de metilato de magnesio carbonizado en metanol, asi como su elaboracion y empleo.
IN173987B (ru)
HUT42264A (en) Insecticide and acaricide compositions containing benzoyl-carbamide derivatives as active ingredients and process for preparing the active ingredients
EP0657412A4 (ru)